Nanobiotix S.A. (NBTX)

Nanobiotix Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	75.28	41.39	83.92	119.15	35.09
Cash & Cash Equivalents	75.28	41.39	83.92	119.15	35.09
Cash Growth	81.90%	-50.68%	-29.57%	239.52%	-3.06%
Receivables	0.91	0.1	0	0.06	0.01
Other Current Assets	11.15	10.87	9.14	6.04	11.02
Total Current Assets	87.34	52.36	93.06	125.25	46.13
Property, Plant & Equipment	6.25	7.12	8.19	8.26	9.39
Long-Term Investments	0.3	0.29	0.52	0.51	0.53
Goodwill and Intangibles	0.01	0	0	0.02	0.16
Other Long-Term Assets	0	-0	0	0	0
Total Long-Term Assets	6.56	7.41	8.71	8.78	10.08
Total Assets	93.9	59.77	101.77	134.03	56.21
Accounts Payable	18.24	9.62	6.48	7.11	7.77
Deferred Revenue	18.23	16.57	16.77	0	0
Current Debt	5.02	4.56	8.2	4.87	1.09
Other Current Liabilities	8.39	7.18	5.39	7.06	5.49
Total Current Liabilities	49.87	37.94	36.85	19.04	14.35
Long-Term Debt	45.54	48.61	37.82	44.11	43.44
Other Long-Term Liabilities	0.32	0.27	0.32	0.41	0.33
Total Long-Term Liabilities	45.87	48.88	38.13	44.52	43.77
Total Liabilities	95.74	86.81	74.98	63.56	58.11
Total Debt	50.57	53.17	46.02	48.98	44.53
Debt Growth	-4.90%	15.53%	-6.04%	10.00%	116.98%
Retained Earnings	-316.51	-284.32	-230.46	-186.66	-155.98
Comprehensive Income	0.74	0.7	0.64	0.56	0.43
Shareholders' Equity	-1.84	-27.05	26.79	70.47	-1.91
Net Cash / Debt	24.72	-11.78	37.9	70.17	-9.43
Net Cash / Debt Growth	-	-	-45.99%	-	-
Working Capital	37.47	14.42	56.22	106.21	31.78
Book Value Per Share	-0.05	-0.78	0.77	2.17	-0.06

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).